Titan Pharmaceuticals Inc Cash Flow Reinvestment Rate

Latest as of June 2016: 0.00x

Titan Pharmaceuticals Inc cash flow reinvestment rate. Titan Pharmaceuticals Inc (TTNP) has a Cash Flow Reinvestment Rate of 0.00x as of June 2016, reinvesting $9.00K (capex $9.00K ) from operating cash flow of $13.51 Million. Explore Titan Pharmaceuticals Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

$9.00K
Capex + Investments

Operating Cash Flow

$13.51 Million
USD

Capital Expenditures

$9.00K
USD

Cash Flow Reinvestment Rate of Titan Pharmaceuticals Inc (1997–2016)

Cash flow reinvestment rate of Titan Pharmaceuticals Inc from 1997 to 2016. Historical reinvestment intensity for Titan Pharmaceuticals Inc across 3 annual periods. Explore capital reinvestment ratio of Titan Pharmaceuticals Inc to see what proportion of operating cash flow is directed to capital expenditures.

Titan Pharmaceuticals Inc Cash Flow Reinvestment Rate by Year (1997–2016)

Titan Pharmaceuticals Inc cash flow reinvestment rate by year from 1997 to 2016. Year-by-year capital reinvestment analysis for Titan Pharmaceuticals Inc. For the full cash flow conversion analysis, see how efficiently does Titan Pharmaceuticals Inc generate cash.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2016 0.05x $342.00K $6.29 Million $171.00K ▼ -91.4%
2012 0.63x $1.15 Million $1.83 Million $1.15 Million ▲ +4377.3%
1997 0.01x $100.00K $7.10 Million $100.00K —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow